Literatur
-
1
The RALES Investigators .
Effectiveness of spironolactone added to an angiotensin
converting enzyme inhibitor and a loop diuretic for severe chronic congestive
heart failure (the Randomized Aldactone Evaluation Study
[RALES]).
Am J
Cardiol.
1996;
78
902-907
-
2
Bonow R O.
The hibernating myocardium: implications for management of
congestive heart failure.
Am J
Cardiol.
1995;
75
17A-25A
-
3
Bristow M R, Feldman A M, Saxon L A.
Heart failure management using implantable devices for
ventricular resynchronization: Comparison of Medical Therapy, Pacing, and
Defibrillation in Chronic Heart Failure (COMPANION) trial. COMPANION Steering
Committee and COMPANION Clinical Investigators.
J Cardiol
Failure.
2000;
6
276-285
-
4
Cleland J G, John J, Dhawan J. et al .
What is the optimal medical management of ischaemic heart
failure?.
Br Med
Bull.
2001;
59
135-158
-
5
Cribier A, Eltchaninoff H, Bash A. et al .
Percutaneous transcatheter implantation of an aortic valve
prosthesis for calcific aortic stenosis: first human case
description.
Circulation.
2002;
106
3006-3008
-
6
Futterman L G, Lemberg L.
Hibernating myocardium, stunning, ischemic preconditioning:
clinical relevance.
Am J Crit
Care.
2000;
9
430-436
-
7
Givertz M M.
Underlying causes and survival in patients with heart
failure.
N Engl J
Med.
2000;
342
1120-1122
-
8
Hetzer R, Jurmann M J, Potapov E V. et al .
Heart assist systems-current
status.
Herz.
2002;
27
407-417
-
9
Hoppe U C, Erdmann E.
Guidelines for the treatment of chronic heart failure. Issued
by the Executive Committee of the German Society of Cardiology-Heart and
Circulation Research, compiled on behalf of the Commission of Clinical
Cardiology in cooperation with Pharmaceutic Commission of the German
Physicians’ Association.
Z
Kardiol.
2001;
90
218-237
-
10
Hunt S A, Baker D W, Chin M H. et al .
ACC/AHA guidelines for the evaluation and management of
chronic heart failure in the adult: executive summary.
J Heart Lung
Transplant.
2002;
21
189-203
-
11
Kao W, Surjancev B P.
Management of acute heart failure
exacerbation.
Crit Care
Clin.
2001;
17
321-335
-
12
Levy D, Kenchaiah S, Larson M G. et al .
Long-term trends in the incidence of and survival with heart
failure.
N Engl J
Med.
2002;
347
1397-1402
-
13
Packer M, Fowler M B, Roecker E B. et al .
Effect of carvedilol on the morbidity of patients with severe
chronic heart failure: results of the carvedilol prospective randomized
cumulative survival (COPERNICUS)
study.
Circulation.
2002;
106
2194-2199
-
14
Poole-Wilson P A.
Treatment of acute heart failure: out with the old, in with
the new.
J Am Med
Assoc.
2002;
287
1578-1580
-
15
Solomon S D, Glynn R J, Greaves S. et al .
Recovery of ventricular function after myocardial infarction
in the reperfusion era: the healing and early afterload reducing therapy
study.
Ann Intern
Med.
2001;
134
451-458
-
16
Swedberg K, Kjekshus J.
Effects of enalapril on mortality in severe congestive heart
failure: results of the Cooperative North Scandinavian Enalapril Survival Study
(CONSENSUS).
Am J
Cardiol.
1988;
62
60A-66A
-
17
Weber K T.
Aldosterone in congestive heart failure.
N Engl J
Med.
2001;
345
1689-1697
Prof. Dr. med. H. R. Figulla
Klinik für Innere Medizin I, Klinikum der
Friedrich-Schiller-Universität Jena
Erlanger Allee 101
07747 Jena
Phone: 03641/939331
Fax: 03641/939494
Email: Ingrid.Nebe@med.uni-jena.de
